ONON stock forecast 2025 refers to the predicted performance of Onconova Therapeutics, Inc. (ONON) stock over the next few years. It is important for investors to consider stock forecasts as they can provide valuable insights into the potential growth and profitability of a company.
ONON is a clinical-stage biopharmaceutical company focused on discovering and developing novel cancer therapies. The company’s lead product candidate, rigosertib, is a small molecule that targets multiple signaling pathways involved in cancer growth and survival. Rigosertib is currently being evaluated in several clinical trials for the treatment of various types of cancer, including lung cancer, breast cancer, and pancreatic cancer.
